Abstract
Forty-nine patients admitted to a Coronary Care Unit with myocardial infarction complicated by left ventricular failure, were treated with 1.75 mg Lanoxin over 36 hours. Serum digoxin levels were measured by radioimmunoassay at 8, 24, and 48 hours. No difference in serum levels was observed between those patients who received 'old' (reduced bioavailability) and those who received 'new' Lanoxin. Serum levels were significantly higher at 8 and 24 hours in those patients who received their first dose intramuscularly compared with those who received their first dose orally, irrespective of the bioavailability of the oral preparation used. No correlation was observed between serum digoxin levels and serum urea or creatinine during the 48-hour period of study. The incidence of arrhythmias is reported, but no conclusion can be drawn as to whether or not the glycoside contributed to this in any way. The use of digoxin in patients with acute myocardial infarction complicated by left ventricular failure is justifiable in the light of available evidence. However, in view of the possible predisposition of such patients to toxicity, lower serum levels than were achieved in many of our patients seem desirable and a modified dosage schedule is suggested.
Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BING R. J., MARAIST F. M., DAMMANN J. F., Jr, DRAPER A., Jr, HEIMBECKER R., DALEY R., GERARD R., CALAZEL P. Effect of strophanthus on coronary blood flow and cardiac oxygen consumption of normal and failing human hearts. Circulation. 1950 Oct;2(4):513–516. doi: 10.1161/01.cir.2.4.513. [DOI] [PubMed] [Google Scholar]
- BLAIN J. M., EDDLEMAN E. E., SIEGEL A., BING R. J. Studies on myocardial metabolism. V. The effects of lanatoside-C on the metabolism of the human heart. J Clin Invest. 1956 Mar;35(3):314–321. doi: 10.1172/JCI103280. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DOHERTY J. E., PERKINS W. H. STUDIES FOLLOWING INTRAMUSCULAR TRITIATED DIGOXIN IN HUMAN SUBJECTS. Am J Cardiol. 1965 Feb;15:170–174. doi: 10.1016/0002-9149(65)90451-0. [DOI] [PubMed] [Google Scholar]
- Huffman D. H., Azarnoff D. L. Absorption of orally given digoxin preparations. JAMA. 1972 Nov 20;222(8):957–960. [PubMed] [Google Scholar]
- Johnson B. F., Fowle A. S., Lader S., Fox J., Munro-Faure A. D. Biological availability of digoxin from Lanoxin produced in the United Kingdom. Br Med J. 1973 Nov 10;4(5888):323–326. doi: 10.1136/bmj.4.5888.323. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Karliner J. S., Braunwald E. Present status of digitalis treatment of acute myocardial infarction. Circulation. 1972 Apr;45(4):891–902. doi: 10.1161/01.cir.45.4.891. [DOI] [PubMed] [Google Scholar]
- Morris J. J., Jr, Taft C. V., Whalen R. E., McIntosh H. D. Digitalis and experimental myocardial infarction. Am Heart J. 1969 Mar;77(3):342–355. doi: 10.1016/0002-8703(69)90190-2. [DOI] [PubMed] [Google Scholar]
- New formulation of digoxin. Lancet. 1972 Oct 28;2(7783):922–923. [PubMed] [Google Scholar]
- Norris R. M., Mercer C. J., Croxson M. S. Conduction disturbances due to anteroseptal myocardial infarction and their treatment by endocardial pacing. Am Heart J. 1972 Oct;84(4):560–566. doi: 10.1016/0002-8703(72)90480-2. [DOI] [PubMed] [Google Scholar]
- SARNOFF S. J., GILMORE J. P., WALLACE A. G., SKINNER N. S., Jr, MITCHELL J. H., DAGGETT W. M. EFFECT OF ACETYL STROPHANTHIDIN THERAPY ON CARDIAC DYNAMICS, OXYGEN CONSUMPTION AND EFFICIENCY IN THE ISOLATED HEART WITH AND WITHOUT HYPOXIA. Am J Med. 1964 Jul;37:3–13. doi: 10.1016/0002-9343(64)90207-4. [DOI] [PubMed] [Google Scholar]
- Sanchez N., Sheiner L. B., Halkin H., Melmon K. L. Pharmacokinetics of digoxin: interpreting bioavailability. Br Med J. 1973 Oct 20;4(5885):132–134. doi: 10.1136/bmj.4.5885.132. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Smith T. W., Butler V. P., Jr, Haber E. Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay. N Engl J Med. 1969 Nov 27;281(22):1212–1216. doi: 10.1056/NEJM196911272812203. [DOI] [PubMed] [Google Scholar]
- Sonnenblick E. H., Ross J., Jr, Covell J. W., Kaiser G. A., Braunwald E. Velocity of contraction as a determinant of myocardial oxygen consumption. Am J Physiol. 1965 Nov;209(5):919–927. doi: 10.1152/ajplegacy.1965.209.5.919. [DOI] [PubMed] [Google Scholar]
- Stewart M. J., Simpson E. New formulation of lanoxin: expected plasma levels of digoxin. Lancet. 1972 Sep 9;2(7776):541–541. doi: 10.1016/s0140-6736(72)91937-x. [DOI] [PubMed] [Google Scholar]
